Polus is an AI-driven solution for pharmaceutical medical affairs. It analyzes MSL (Medical Science Liaison) engagements with HCPs (Healthcare Professionals) to provide insights beyond traditional, periodic ATU (Awareness, Trial, and Usage) studies. The product uses sentiment analysis, topic analysis, and summarization to give a real-time understanding of HCP perceptions. This continuous feedback loop helps commercial and marketing teams to refine their strategies pre-launch,

We're excited to share that a recent academic paper co-authored by our Data Scientist. Ling-Yu Cai, along with a team of MD/PhD...

Why “writing problems” aren’t really about writing If you’ve ever said: “This draft doesn’t sound right.”  “It’s not what I meant.” ...

In a world flooded with writing tools, the real bottleneck isn't typing speed. It's planning structure and clarity, before the first word...

Author:  Ting-Yuan Wang, Solution Architect at Vizuro Realities of AI Implementation Over the past eight years, Vizuro has witnessed the rapid development and widespread application of AI across various industries. According to our client statistics, AI applications are most prevalent in the healthcare sector, accounting for 34%, followed by 25% in the pharmaceutical and life sciences industries, and 23% in manufacturing. Despite the enthusiasm and expectations surrounding AI

Empowering Clinicians and General Populations with Actionable Insights Diabetes is one of the world’s fastest-growing health crises,...

How CorePal uses GenAI to potentially recycle 98% of the valuable parts from junkyards to foster a circular economy With today's...

Authors: Drs. Hung-Ken Chien and Yu-Feng Wei, Co-Founders of Vizuro Introduction In the ever-evolving pursuit to measure promotional effectiveness, marketing mix modeling (MMM) has long been the norm to assess campaign lifts and help allocate their spending. However, the emergence of omnichannel marketing in recent years has imposed a great challenge to the conventional MMM methodology, due to its requirements for high tactic mix and segment granularity. Coincidentally, both

Expanding Global Reach with Kolr's Rebranding and Cutting-Edge AI Technologies (Left to right) Vizuro Co-founder and CEO, Yu-Feng Wei;...

Fig 1.  Adaptyv Bio “Protein Design Competition Round2” Competition Overview Protein binding remains one of the most challenging aspects...

Vizuro and DCB announced the signing of a Memorandum of Understanding (MOU) Vizuro LLC, a leading innovator in multimodal causal AI...

We are thrilled to announce that Vizuro has joined NVIDIA Inception , a program that nurtures startups revolutionizing industries with...

Key Takeaways: The 2024 Nobel Prize in Chemistry was awarded for groundbreaking advancements in computational protein structure...